Skip to main content
Premium Trial:

Request an Annual Quote

Arizona Entrepreneur Pledges $3M to TGen for Breast Cancer Research

NEW YORK, April 6 (GenomeWeb News) - The Translational Genomics Research Institute said on Monday that an Arizona entrepreneur had pledged $3 million to support three breast cancer research projects.


The projects include a study to enable physicians to diagnose and treat patients who have a genetic predisposition for developing breast cancer; a study to determine which tumors are most likely to respond to a particular therapy; and a prospective study based on the previous two studies to determine the most effective treatments for individual tumors based on their genetic information.


The entrepreneur, Ray Thurston, who founded a courier company that was acquired by United Parcel Service in 1995, also plans to assist TGen in "streamlining processes that expedite research and ultimately reduce the time required for the development of new diagnostic tests and drug treatments," according to the institute.


TGen researchers have already begun training Thurston in "molecular biology, including mandatory lessons in laboratory safety," TGen said.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.